pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·22h ago·1 min read
save

Over a third of biotech and pharma workers stay in their jobs for health insurance, poll shows

Aug 5, 2026·read at BioSpace ↗Negative

A recent BioSpace LinkedIn poll and a joint study by West Health and Gallup found that a significant share of biotech and pharma employees remain in their current roles primarily to keep health insurance coverage.

The study reported that 24% of U.S. workers overall stay in jobs they want to leave because of insurance concerns, up from 16% in 2021. In the biopharma sector, 39% of respondents said they would prefer to leave but stay for the same reason.

Gallup highlighted that about half of Americans struggle to afford medical care or prescriptions, and 51% worry about covering healthcare costs in the next year, the highest level in five years.

Recruiters note that the lack of alternative positions makes health benefits a decisive factor for many biopharma professionals considering a job change.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Over 1/3 stay in biopharma jobs for health insurance, poll finds”

read at BioSpace ↗
860 words · retrieved 22h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Big PharmaCRO/CDMO

related stories

  • 6h agoCROs vs. biotechs: Finding the right fitBioSpace
  • 23h agoPfizer ramps up ongoing restructuring, Lisata axes 72% of staffBioSpace
  • 3d agoBiotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls outBioSpace
  • Jul 27From confidence to capital: Positioning biotech for the next growth cycleBioPharma Dive
  • Jul 23From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotechFierce Biotech